- Home
- PBYI vs ZH Comparison
PBYI vs ZH Comparison
Compare PBYI & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | ZH |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 307.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PBYI | ZH |
|---|---|---|
| Price | $5.96 | $3.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 372.8K | 274.0K |
| Earning Date | 11-06-2025 | 11-25-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.87 | N/A |
| EPS | ★ 0.74 | 0.17 |
| Revenue | $211,995,000.00 | ★ $416,437,241.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $8.01 | $20.08 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.58 | $3.19 |
| 52 Week High | $6.12 | $6.32 |
Technical Indicators
Market Signals| Indicator | PBYI | ZH |
|---|---|---|
| Relative Strength Index (RSI) | 66.14 | 39.68 |
| Support Level | $5.51 | $3.29 |
| Resistance Level | $5.73 | $3.58 |
| Average True Range (ATR) | 0.22 | 0.13 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 95.76 | 43.48 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.